Reuters logo
BRIEF-Aurobindo Pharma says US FDA issued form 483 with 6 observations for unit-III
April 19, 2017 / 9:15 AM / 5 months ago

BRIEF-Aurobindo Pharma says US FDA issued form 483 with 6 observations for unit-III

April 19 (Reuters) - Aurobindo Pharma Ltd

* Clarifies on news item “US FDA issues 5-6 ‘largely procedural’ observations to Aurobindo Pharma’s Unit-III”

* Says have been issued a form 483 with 6 observations

* Observations are all on procedural improvements

* Says none of observations related to data integrity Source text - (bit.ly/2omdvev) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below